13D

Company

Theriva Biologics, Inc.

Filed

November 17, 2006

Accession Number

0000890163-06-000763

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →